The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis

被引:0
|
作者
Huy Gia Vuong
Thu Quynh Nguyen
Tam N. M. Ngo
Hoang Cong Nguyen
Kar-Ming Fung
Ian F. Dunn
机构
[1] Oklahoma University Health Sciences Center,Department of Pathology
[2] Oklahoma University Health Sciences Center,Stephenson Cancer Center
[3] Pham Ngoc Thach University of Medicine,Faculty of Medicine
[4] Oklahoma University Health Sciences Center,Department of Neurosurgery
来源
BMC Cancer | / 20卷
关键词
Glioma; Glioblastoma; TERT; MGMT; Temozolomide; Overall survival; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
    Arita, Hideyuki
    Yamasaki, Kai
    Matsushita, Yuko
    Nakamura, Taishi
    Shimokawa, Asanao
    Takami, Hirokazu
    Tanaka, Shota
    Mukasa, Akitake
    Shirahata, Mitsuaki
    Shimizu, Saki
    Suzuki, Kaori
    Saito, Kuniaki
    Kobayashi, Keiichi
    Higuchi, Fumi
    Uzuka, Takeo
    Otani, Ryohei
    Tamura, Kaoru
    Sumita, Kazutaka
    Ohno, Makoto
    Miyakita, Yasuji
    Kagawa, Naoki
    Hashimoto, Naoya
    Hatae, Ryusuke
    Yoshimoto, Koji
    Shinojima, Naoki
    Nakamura, Hideo
    Kanemura, Yonehiro
    Okita, Yoshiko
    Kinoshita, Manabu
    Ishibashi, Kenichi
    Shofuda, Tomoko
    Kodama, Yoshinori
    Mori, Kanji
    Tomogane, Yusuke
    Fukai, Junya
    Fujita, Koji
    Terakawa, Yuzo
    Tsuyuguchi, Naohiro
    Moriuchi, Shusuke
    Nonaka, Masahiro
    Suzuki, Hiroyoshi
    Shibuya, Makoto
    Maehara, Taketoshi
    Saito, Nobuhito
    Nagane, Motoo
    Kawahara, Nobutaka
    Ueki, Keisuke
    Yoshimine, Toshiki
    Miyaoka, Etsuo
    Nishikawa, Ryo
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 : 79
  • [22] The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
    Binabaj, Maryam Moradi
    Bahrami, Afsane
    ShahidSales, Soodabeh
    Joodi, Marjan
    Mashhad, Mona Joudi
    Hassanian, Seyed Mahdi
    Anvari, Kazem
    Avan, Amir
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) : 378 - 386
  • [23] Association of human telomerase reverse transcriptase promoter mutation with unfavorable prognosis in glioma: A systematic review and meta-analysis
    Hua, Rongxuan
    Li, Qiuxuan
    Gao, Han
    Wang, Boya
    He, Chengwei
    Wang, Ying
    Zhang, Sitian
    Gao, Lei
    Shang, Hongwei
    Wang, Wen
    Xu, Jingdong
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2023, 28 (01): : 47
  • [24] The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis
    Zhang, Kui
    Wang, Xiao-qin
    Zhou, Bin
    Zhang, Lin
    FAMILIAL CANCER, 2013, 12 (03) : 449 - 458
  • [25] The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis
    Kui Zhang
    Xiao-qin Wang
    Bin Zhou
    Lin Zhang
    Familial Cancer, 2013, 12 : 449 - 458
  • [26] Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients
    Giunco, S.
    Padovan, M.
    Angelini, C.
    Cavallin, F.
    Cerretti, G.
    Morello, M.
    Caccese, M.
    Rizzo, B.
    d'Avella, D.
    Puppa, A. D.
    Chioffi, F.
    De Bonis, P.
    Zagonel, V.
    De Rossi, A.
    Lombardi, G.
    ESMO OPEN, 2023, 8 (03)
  • [27] Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method
    von Rosenstiel, Charlotte
    Wiestler, Benedikt
    Haller, Bernhard
    Schmidt-Graf, Friederike
    Gempt, Jens
    Bettstetter, Marcus
    Rihani, Laura
    Wu, Wei
    Meyer, Bernhard
    Schlegel, Juergen
    Liesche-Starnecker, Friederike
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (02) : 112 - 115
  • [28] Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma
    Zhang, Yang
    Zhu, Junwei
    ONCOLOGY REPORTS, 2019, 41 (02) : 908 - 916
  • [29] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
    Kavouridis, Vasileios K.
    Ligon, Keith L.
    Wen, Patrick Y.
    Iorgulescu, J. Bryan
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) : 111 - 116
  • [30] Survival outcomes associated with MGMT promoter methylation and temozolomide in gliosarcoma patients
    Vasileios K. Kavouridis
    Keith L. Ligon
    Patrick Y. Wen
    J. Bryan Iorgulescu
    Journal of Neuro-Oncology, 2022, 158 : 111 - 116